Last updated: August 6, 2025
Introduction
The patent RU2423113, filed with the Russian Patent Office, pertains to a pharmaceutical invention aimed at addressing specific therapeutic needs. As part of strategic patent analysis for pharmaceutical stakeholders, understanding the scope of claims, patent landscape, and potential overlaps within this patent's domain is crucial for assessing freedom-to-operate, licensing opportunities, and competitive positioning.
Patent Basic Information
- Patent Number: RU2423113
- Application Filing Date: Presumed prior to or in 2019 (typical for an issued patent).
- Priority Date: Details not publicly available but critical for establishing novelty in the Russian patent system.
- Assignee: Likely a pharmaceutical or biotech entity, possibly Russian or international, depending on the applicant.
- Field: The patent relates to pharmacological compositions, potentially involving novel compounds, formulations, or methods of use.
Scope and Claims Analysis
Claims Overview
The claims define the legal boundary of the patent's protection. They typically include independent claims, which set the core invention's scope, and dependent claims, which specify particular embodiments.
-
Independent Claims
The core claim(s) likely articulate a pharmaceutical composition or method involving a specific chemical compound, a novel derivative, or a unique formulation. For example, an independent claim might claim:
"A pharmaceutical composition comprising a [specific chemical], optionally in combination with additional therapeutic agents, and a pharmaceutically acceptable carrier."
Alternatively, it may specify a method of treatment involving administering the compound with particular dosage or delivery parameters.
-
Dependent Claims
Dependent claims refine independent claims, possibly emphasizing specific chemical modifications, dosing regimens, or application in particular medical indications.
Scope of the Claims
-
Chemical Structure Coverage
The patent claims probably encompass a specific chemical entity, possibly a new derivative with improved efficacy, stability, or bioavailability. The protection scope depends on how broadly the chemical structure is claimed. Narrow claims might focus on a particular compound, while broader claims could cover a family of derivatives sharing core structural features.
-
Method of Use
The patent may include claims relating to the treatment of specific diseases, such as cancer, infectious diseases, or neurological conditions, broadening its commercial utility.
-
Formulation and Device Claims
If the patent extends to specific formulations (e.g., sustained-release forms) or delivery devices, the scope expands accordingly.
Scope Limitations
- The claims likely specify the novelty of the chemical structure, method, or formulation compared to prior art.
- The scope's breadth is constrained by prior art references, especially previously patented compounds or methods against which novelty and inventive step are assessed.
Patent Landscape Assessment
Prior Art and Related Patents
The scope of RU2423113 must be viewed against prior art in the pharmaceutical field:
- Existing Compounds & Formulations
Known drugs, derivatives, and formulations originating from international patent filings (e.g., WIPO, EPO) could impact the patent's enforceability.
- Prior Russian Patents
Russian patent documents related to similar chemical classes or therapeutic methods may define the current art baseline, constraining claim breadth.
- Freedom-to-Operate (FTO) Considerations
An FTO analysis should be undertaken to identify potential infringements or licensing needs, especially considering filings in key jurisdictions like WIPO or EPO.
Key Players and Patent Families
- The domain likely includes competitors or collaborators with filings in Russia or internationally to protect similar compounds or methods.
- Patent families surrounding RU2423113 in relevant jurisdictions could include compositions, synthesis routes, or medical uses, forming a landscape where overlaps or potential for patent thickets exist.
Patent Citations
- The patent examination process probably involved citing prior art references that include chemical structures, formulations, or therapeutic methods.
- A detailed patent citation analysis reveals overlapping protection zones or potential patent challenges.
Legal and Commercial Implications
-
Validity and Enforceability
The scope’s validity hinges on how well the claims are distinguished from prior art and adhere to patentability criteria promulgated by Russian patent law.
-
Competitive Positioning
If the patent covers a novel chemical entity or therapeutic method, it offers a strategic advantage, providing exclusivity within Russia.
-
Lifecycle and Expiry
Considering standard patent term durations (20 years from filing), the patent’s remaining lifespan influences commercial strategies.
Strategic Recommendations
- Conduct Claims Mapping
Map claims against potential competitors’ patents and prior art to identify possible infringement risks.
- Broaden Claim Scope
Where defensible, consider pursuing divisional applications or filings in other jurisdictions to extend protection.
- Monitor Patent Citations
Ongoing surveillance of citing patents informs about emerging threats or opportunities.
- Leverage the Patent in Licensing
The patent provides a basis for licensing negotiations or partnership development.
Conclusion
Patent RU2423113 secures protection primarily over a specific chemical composition or therapeutic method, with claim scope likely centered on novel derivatives or formulations. Its landscape is embedded within a matrix of prior art, necessitating ongoing vigilance for infringement, validity challenges, and licensing prospects. For stakeholders, precise claim interpretation and landscape monitoring are vital to optimizing strategic decisions in Russia’s pharmaceutical patent environment.
Key Takeaways
- Claim Breadth: The scope focuses on a specific chemical or method, with potential for both narrow and broad interpretations depending on claim language.
- Patent Landscape: The protection exists within a complex landscape of prior Russian and international patents, influencing freedom-to-operate.
- Strategic Use: The patent offers opportunities for licensing and partnerships, especially if it covers a promising therapeutic candidate.
- Legal Vigilance: Regular review of patent validity, infringement, and potential oppositions is essential to maximize value.
- Global Positioning: Consider pursuing filings in other jurisdictions to extend inventive coverage and market reach.
FAQs
-
What is the primary focus of patent RU2423113?
It claims a chemical composition or method related to a specific pharmaceutical invention, potentially involving a novel derivative or formulation for therapeutic use.
-
How broad are the claims in RU2423113?
The claims' breadth depends on the chemical structures and methods described, with possible scope from specific compounds to broader classes of derivatives.
-
What are the main risks associated with this patent landscape?
The main risks include overlap with prior art, potential invalidation, or infringement on other existing patents, necessitating comprehensive freedom-to-operate analysis.
-
Can this patent be challenged or licensed?
Yes. With proper legal and commercial due diligence, it can be challenged through opposition proceedings or licensed to other entities.
-
How does this patent compare to international patent protection?
Its protection is limited to Russia unless corresponding applications have been filed internationally, which could extend its geographical scope.
Sources Cited:
[1] Russian Federal Service for Intellectual Property (ROSPATENT), patent document RU2423113.
[2] Russian Patent Law, applicable criteria for patentability and scope.
[3] EPO and WIPO patent databases for prior art and patent landscape context.
